PsychBright Health is a psychiatry practice offering medically supervised in-home opioid detox to patients across California. Board-certified psychiatrists. Buprenorphine prescribed and managed remotely. Same-week starts available within 5 business days. Aetna, Blue Shield, Medicare, and Medicare Advantage accepted.
In-home opioid detox is medically supervised withdrawal management conducted in the patient’s own home rather than a hospital or residential facility, using FDA-approved medications to reduce the severity of withdrawal symptoms and cravings while a board-certified psychiatrist monitors progress remotely. For many patients, the ability to detox privately, without leaving their home or disclosing their situation to an employer or family members, is the difference between starting treatment and putting it off indefinitely.
According to the Substance Abuse and Mental Health Services Administration, fewer than 25 percent of people with opioid use disorder receive any form of treatment. One of the most consistent barriers is access — the logistical, financial, and social difficulty of entering a detox facility. In-home detox removes most of those barriers while maintaining the medical oversight that makes detox safe.
The process begins with a comprehensive psychiatric evaluation conducted via telehealth. Your psychiatrist reviews your opioid use history, current medications, general health status, and home environment to confirm that in-home detox is clinically appropriate for your situation. If it is, your buprenorphine prescription is sent electronically to your pharmacy before your detox start date.
Once you begin, your psychiatrist monitors your progress through scheduled telehealth check-ins, typically daily during the first week when withdrawal symptoms are most intense. Medication is adjusted based on your reported symptoms. If anything requires urgent attention, our team is available to respond. The goal throughout is to keep withdrawal symptoms manageable while moving you toward stabilization as efficiently as possible.
| Stage | Timeline | What to Expect |
|---|---|---|
| Evaluation | Before start | Telehealth psychiatric evaluation. Buprenorphine prescribed if appropriate. Pharmacy confirmed. |
| Induction | Days 1 to 3 | Buprenorphine initiated once mild to moderate withdrawal is present. Dosage titrated to comfort. Daily check-ins with your psychiatrist. |
| Stabilization | Days 4 to 14 | Dose stabilized at the level that eliminates cravings and controls withdrawal. Check-ins every two to three days. Physical symptoms improving significantly. |
| Transition | Week 2 onward | Shift from acute detox to maintenance treatment or structured taper depending on your goals. Connection to ongoing MAT, therapy coordination, and recovery support. |
Buprenorphine is a partial opioid agonist approved by the FDA specifically for opioid use disorder. It works by binding to the same receptors as opioids without producing the full euphoric effect, which means it suppresses withdrawal symptoms and cravings without creating a new dependence cycle. It is the most widely studied and most effective medication available for opioid withdrawal management.
At PsychBright Health, buprenorphine is prescribed and managed by board-certified psychiatrists, not automated platforms or nurse-only telehealth services. Your prescribing physician reviews your case personally, monitors your response, and adjusts your dose based on clinical judgment rather than algorithm output.
Buprenorphine is available in several formulations. Suboxone combines buprenorphine with naloxone, which discourages misuse. Subutex is buprenorphine alone, used in specific clinical situations. Your psychiatrist will determine which formulation is most appropriate based on your medical history and treatment goals.
Buprenorphine addresses the core withdrawal syndrome, but other symptoms sometimes require additional support. Depending on your specific symptom profile, your psychiatrist may also prescribe:
Every medication decision is made by your board-certified psychiatrist based on your reported symptoms and medical history. Nothing is prescribed automatically.
In-home detox is clinically appropriate for many patients with opioid use disorder, but it is not the right option for everyone. Your psychiatrist will assess your situation at the initial evaluation and make an honest recommendation based on your clinical picture, not on what is most convenient to offer.
In-home detox is generally appropriate when:
If your clinical situation requires a higher level of care, your psychiatrist will tell you directly and provide referrals to appropriate inpatient or residential detox programs. We do not fit patients into programs that are not right for them.
Facility-based detox serves an important role for patients who need intensive medical monitoring. For patients who do not require that level of care, in-home detox offers real advantages that can directly affect whether treatment succeeds.
Detox is not treatment for opioid use disorder. It is the first step. Completing detox without transitioning to ongoing treatment carries a high risk of relapse, and relapse after a period of abstinence carries a significantly elevated overdose risk because tolerance drops during detox.
At PsychBright Health, every in-home detox patient transitions directly into an ongoing treatment plan. This typically includes:
You will not be discharged from care at the end of your detox period without a clear, confirmed plan for what comes next.
PsychBright Health brings together board-certified psychiatrists who specialize in addiction psychiatry and opioid use disorder, same-week availability for most patients within 5 business days, and telehealth-based care available to any California resident. We prescribe and manage buprenorphine directly, meaning your detox is supervised by a physician with full prescribing authority rather than a mid-level provider operating under a remote physician’s license. We accept Aetna, Blue Shield, UHC, Cigna, Anthem, Medicare, and Medicare Advantage, including Medicare Advantage plans that many addiction treatment providers do not accept. Bilingual care in Spanish is also available.
If you have tried to access detox before and found the barriers too high, or if you simply need to manage this privately without entering a facility, request an appointment online or call (213) 584-2331. Most patients are seen within 5 business days.
If you or someone you know is in crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Yes, for patients who are appropriate candidates. Your psychiatrist evaluates your medical history, current opioid use, and home situation before recommending in-home detox. Patients with serious medical complications that require continuous monitoring are directed to higher levels of care. For medically appropriate patients, buprenorphine-assisted in-home detox is safe and has strong evidence supporting its effectiveness. Daily telehealth check-ins during the first week ensure your psychiatrist can respond quickly to any concerns.
Opioid withdrawal produces intense physical discomfort including severe muscle aches, sweating, chills, nausea, vomiting, diarrhea, anxiety, insomnia, and an overwhelming craving to use. Symptoms typically peak 36 to 72 hours after the last dose for short-acting opioids such as heroin, and later for long-acting opioids such as methadone. Buprenorphine, when initiated at the right point in withdrawal, significantly reduces all of these symptoms within hours of the first dose. Most patients report dramatic improvement by the end of day one of induction.
The acute withdrawal phase typically lasts 5 to 10 days for short-acting opioids and longer for long-acting opioids such as methadone or extended-release formulations. Physical symptoms are most intense in the first 72 hours and improve significantly by day 4 to 5 for most patients. Post-acute withdrawal symptoms including mood disturbance, sleep problems, and low energy can persist for weeks to months. Transitioning to ongoing buprenorphine maintenance after detox addresses these prolonged symptoms and significantly reduces relapse risk.
Yes. Under current federal guidelines, buprenorphine for opioid use disorder can be prescribed via telehealth without an in-person visit. Your initial evaluation is conducted by video, and subsequent check-ins are also via telehealth. Prescriptions are sent electronically to your pharmacy of choice. PsychBright Health is able to provide this service to patients anywhere in California.
Your first appointment is a comprehensive psychiatric evaluation conducted via telehealth, typically 45 to 60 minutes. Your psychiatrist will review your opioid use history, what substances you are using and at what frequency, your last use date, any prior detox or treatment attempts, your current medications and medical history, and your home situation and support network. Based on this evaluation, your psychiatrist will determine whether in-home detox is appropriate and, if so, send your buprenorphine prescription to your pharmacy. Your induction date and check-in schedule will be confirmed before the appointment ends. Bring a list of all current medications.
Yes, but only briefly. Buprenorphine must be initiated after you have entered mild to moderate withdrawal, typically 12 to 24 hours after your last dose of a short-acting opioid. Starting too early, before withdrawal has begun, can precipitate a sudden and severe withdrawal crisis. Your psychiatrist will walk you through exactly when to take your first dose based on your specific situation. You will not be left to figure this out alone.
Relapse during detox is possible, particularly in the early days. It does not mean treatment has failed or that in-home detox was the wrong choice. Contact your psychiatrist immediately if you use during detox. Do not take your next buprenorphine dose until you have spoken with your care team. Using opioids on top of buprenorphine carries real risks and your psychiatrist needs to know before you resume medication. There is no judgment. The clinical priority is your safety and getting back on track as quickly as possible.
No. All psychiatric and addiction treatment at PsychBright Health is protected under HIPAA, and addiction treatment records specifically carry additional federal protections under 42 CFR Part 2, which restricts disclosure more tightly than standard HIPAA. Your employer cannot access your records without your written consent. Your family members cannot either unless you authorize it. In-home detox means there is no facility admission, no hospital record, and no external disclosure of any kind. Your treatment is entirely private.
Yes. PsychBright Health accepts Aetna, Blue Shield, UHC, Cigna, Anthem, Medicare, and Medicare Advantage. The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover substance use disorder treatment at the same level as medical treatment. Call (213) 584-2331 to confirm your specific coverage before your first appointment.
Most patients are seen within 5 business days. For patients in acute need, contact us directly and we will do everything possible to expedite your evaluation. Request an appointment online or call (213) 584-2331 and our team will follow up within one business day.
PsychBright Health – Psychiatrist in Los Angeles
1180 S Beverly Dr #700, Los Angeles, CA 90035
(213) 584-2331
Monday to Friday, 8:00 AM to 5:00 PM
